Published online Apr 21, 2020. doi: 10.3748/wjg.v26.i15.1758
Peer-review started: December 28, 2019
First decision: January 11, 2020
Revised: March 17, 2020
Accepted: March 27, 2020
Article in press: March 27, 2020
Published online: April 21, 2020
Processing time: 114 Days and 20.8 Hours
PTEN-induced putative kinase (PINK1) is a novel regulator of mitochondrial homeostasis that phosphorylates target proteins in mitochondria. PINK1 depletion has been identified to be related to mitochondrial fragmentation, ROS accumulation and apoptosis. However, the underlying regulatory mechanism of PINK1 in intestinal ischemia reperfusion (I/R) injury remains unclear. Therefore, elucidation of the protective role of PINK1 may help to improve tissue repair in I/R injury.
It is necessary to explore the function and target of PINK1 in mitochondrial regulation in intestinal I/R injury. Previous studies have demonstrated that mitochondrial dysfunction-induced apoptosis is an important cause of intestinal mucosal barrier damage and is associated with a high mortality rate in clinical practice. Moreover, the role of PINK1 in the protection against ischemic diseases has been clarified. These findings provide a basis for further study regarding the mechanism and target of PINK1 during intestinal I/R injury.
In a previous study, we investigated the effect of PINK1 on mitochondrial fission after intestinal I/R injury both in vivo and in vitro by gain- and loss-of-function approaches. Furthermore, we explored the phosphorylation site of DRP1, which is a downstream target of PINK1. Our study provides significant insight into the signaling mechanism of PINK1 during intestinal I/R injury and may contribute to the future investigation of more effective therapies in clinical practice.
Experiments used an in vivo mouse model and an in vitro Caco-2 cells models to better elucidate the pathophysiological process of intestinal I/R injury. Hematoxylin and eosin staining, and Chiu’s scoring system were used to demonstrate intestinal tissue injury. TUNEL and mitoSOX staining was carried out to display and observe apoptotic cells and ROS accumulation. Gene silencing and transfection were conducted to construct PINK1-depleted or PINK1-overexpressing cells to complete functional studies in vitro. A series of in vitro experiments, such as Western blotting, Cell Counting Kit-8 assays, and MitoTracker staining, were performed to explore the effect of PINK1 on mitochondrial fission.
Experiments in vivo showed the correlation between PINK1 and mucosal injury after intestinal I/R injury. The results of in vitro experiments showed a direct positive correlation of PINK1 with mitochondrial protection and apoptosis inhibition after hypoxia/reoxygenation. This study could be valuable as a basis for further studies on intestinal I/R injury and could potentially be utilized for therapeutic enhancement in clinical practice. Some limitations did exist: The in vivo study should be better designed to clarify causation and biological linkage, and PINK1 knockout mouse models would be helpful. Clinical samples are also needed to better support the application to human beings.
PINK1 plays a positive role in mitochondrial homeostasis and apoptosis inhibition in intestinal I/R injury. This study reveals that PINK1 could improve the phosphorylation of DRP1 at Ser637. Targeting the PINK1/DRP1 pathway may increase the therapeutic potential for intestinal I/R injury in clinical practice.
Our study illuminates the role of PINK1 in mitochondrial protection in intestinal I/R injury. Other researchers have reported that PINK1 is associated with mitophagy under I/R stress. Thus, the link between PINK1 and mitophagy in intestinal I/R needs further investigation.